Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.220
-0.090 (-2.09%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $544.98 million as of July 31, 2026. Its market cap has increased by 21.20% in one year.
Market Cap
544.98M
Enterprise Value
310.24M
1-Year Change
21.20%
Ranking
Category
Stock Price
$4.22
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $544.98M, a decrease of -75.90%. That is a compound annual growth rate of -24.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 544.98M | -15.60% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 671.21M |
| BrainsWay | 640.41M |
| Tactile Systems Technology | 635.41M |
| Beta Bionics | 577.22M |
| OrthoPediatrics | 518.58M |
| Orthofix Medical | 476.98M |
| Varex Imaging | 471.62M |
| ClearPoint Neuro | 448.04M |